P. Wilson

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

R. D'Agostino, P. Wilson, S. Grundy, 2001, JAMA.

Coronary heart disease risk in men and the epidemic of overweight and obesity

L. Sullivan, P. Wilson, K. Nanchahal, 2005, International Journal of Obesity.

An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas

J Marrugat, R. D'Agostino, W. Kannel, 2003, Journal of epidemiology and community health.

Evaluation of dietary quality in relationship to nutritional and lifestyle factors in elderly people of the US Framingham Heart Study and the European SENECA study

P. Wilson, A. Haveman-Nies, W. V. Staveren, 2001, European Journal of Clinical Nutrition.

A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study

P. Wilson, J. Ordovás, Ej Schaefer, 1999, Clinical genetics.

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.

P. Wilson, J. Ordovás, W. Castelli, 1994, Circulation.

Educational attainment and coronary heart disease risk: the Framingham Offspring Study.

P. Wilson, W. Kannel, R. Garrison, 1993, Preventive medicine.

Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study.

P. Wilson, J. Ordovás, L. Cupples, 2000, Arteriosclerosis, thrombosis, and vascular biology.